Roscovitine, a novel cyclin-dependent kinase inhibitor, characterizes restriction point and G2/M transition in tobacco BY‐2 cell suspension. - Planchais,S..; Glab,N..; Tréhin,C..; Perennes,C..; Bureau,J.-M..; Meijer,L..; Bergounioux,C.. (Plant Journal, 1997)